...
首页> 外文期刊>Healthcare >Who Benefits from Chronic Opioid Therapy? Rethinking the Question of Opioid Misuse Risk
【24h】

Who Benefits from Chronic Opioid Therapy? Rethinking the Question of Opioid Misuse Risk

机译:谁从慢性阿片类药物治疗中受益?重新思考阿片类药物滥用风险的问题

获取原文
           

摘要

Beginning in the late 1990s, a movement began within the pain management field focused upon the underutilization of opioids, thought to be a potentially safe and effective class of pain medication. Concern for addiction and misuse were present at the start of this shift within pain medicine, and an emphasis was placed on developing reliable and valid methods and measures of identifying those at risk for opioid misuse. Since that time, the evidence for the safety and effectiveness of chronic opioid therapy (COT) has not been established. Rather, the harmful, dose-dependent deleterious effects have become clearer, including addiction, increased risk of injuries, respiratory depression, opioid induced hyperalgesia, and death. Still, many individuals on low doses of opioids for long periods of time appear to have good pain control and retain social and occupational functioning. Therefore, we propose that the question, “Who is at risk of opioid misuse?” should evolve to, “Who may benefit from COT?” in light of the current evidence.
机译:从20世纪90年代末开始,一项运动始于止痛管理领域,重点关注阿片类药物的未充分利用,以为是一个潜在安全有效的止痛药。在止痛药物开始时存在对成瘾和滥用的关注,并强调开发可靠和有效的方法和鉴定阿片类药物滥用风险的措施。从那时起,尚未建立慢性阿片类药物治疗(COT)安全性和有效性的证据。相反,有害的剂量依赖性有害效果变得更加清晰,包括成瘾,伤害的风险增加,呼吸抑制,阿片类药物诱导痛觉过敏和死亡。仍然,在长时间低剂量阿片类药物上的许多人似乎具有良好的疼痛控制并留住社会和职业运作。因此,我们提出了这个问题,“谁面临阿片类药物滥用?”应该发展到“谁可以受益于婴儿床?”根据当前的证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号